The Montreal Cognitive Assessment (MoCA) questionnaire is an easy-to-administer, inexpensive, effective screening tool that can identify patients with systemic lupus erythematosus (SLE) who might be at risk for cognitive dysfunction (CD) and might benefit from additional neuropsychiatric assessment, according to data published in Lupus.

The investigators sought to evaluate use of the MoCA test and the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) as screening tools for CD in patients with SLE. Patients with SLE who met the American College of Rheumatology classification criteria were assessed using Automated Neuropsychiatric Assessment Metrics (ANAM) as the reference standard.

For full article please click here.